RTM added as distributor NeuraCeq®
Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F) will soon be available from Radboud Translational Medicine (RTM) in Nijmegen, The Netherlands. We're delighted to announce that the European Medicine Agency has approved the Type IB variation to the NeuraCeq EU dossier, adding RTM to the distribution network.
For more information on NeuraCeq®, including safety information, please visit: https://neuraceq.com/

Other news

Huntington’s Disease: A Review of the Known PET Imaging Biomarkers and Targeting Radiotracers
Klaudia Cybulska (postdoc radiochemistry) has written an article about Huntington's Disease. Abstra...

First Patient Dosed with TLX250-CDx in Italy for ccRCC
The below product is manufactured at RTM First Patient dosed with TLX250-CDx in Italy for ccRCC Th...

18F-FDOPA now available
Fluorodopa (18F) is now available for clinical studies and - with doctor's certificate - for routine...
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany! This marks the 8...
Interested in a collaboration?
Contact us to discuss the possibilities.